复原和转化医学在COPD:作和希望
Lucas Pires Guarnier1,2, Lincoln Gozzi Moro2,3, Francislaine Aparecida Dos Reis Lívero4
1Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.
概括
基于细胞的疗法显示出治疗慢性阻塞性肺病 (COPD) 的前景,这是一个渐进的肺部疾病. 需要进一步的研究来解决关于这种广泛传播的疾病的有效性和最佳应用的问题.
科学领域:
- 再生医学是一种再生医学.
- 肺部医学 肺部医学
- 细胞疗法细胞疗法
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球主要的死亡原因,其特点是慢性炎症和空气流量限制.
- 目前对COPD的治疗方法有限,这凸显了对新型治疗策略的需求.
- 基于细胞的疗法正在成为COPD管理的有希望的方法.
研究的目的:
- 介绍COPD基于细胞的治疗方法的现状.
- 审查已完成的临床试验,并公布结果.
- 确定和讨论COPD细胞基再生医学领域的未解答问题.
主要方法:
- 对COPD细胞疗法发表文献的综述.
- 详细讨论已完成的临床试验及其结果.
- 分析正在进行的研究和剩余的挑战.
主要成果:
- 对于基于细胞的COPD疗法,已发表的研究和正在进行的临床试验有限.
- 现有的研究表明潜在的,但提出了许多关于疗效,机制和管理的问题.
- 要将基于细胞的疗法转化为有效的临床实践,需要取得重大进展.
结论:
- 基于细胞的疗法代表了COPD治疗的潜在突破.
- 为了优化细胞治疗方案并解决安全性和疗效方面的问题,进一步严格的研究是必不可少的.
- 翻译医学的努力对于克服当前的局限性和建立基于细胞的COPD治疗方法至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
COPD: Pathogenesis and Clinical Features
351
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
351
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


